The crypt-villus axis constitutes the functional unit of the small intestine, where mature absorptive cells are confined to the villi, and stem cells and transit amplifying and differentiating cells are restricted to the crypts. The polycomb group (PcG) proteins repress differentiation and promote self-renewal in embryonic stem cells. PcGs prevent transcriptional activity by catalysing epigenetic modifications, such as the covalent addition of methyl groups on histone tails, through the action of the polycomb repressive complex 2 (PRC2). Although a role for PcGs in the preservation of stemness characteristics is now well established, recent evidence suggests that they may also be involved in the regulation of differentiation. Using intestinal epithelial cell models that recapitulate the enterocytic differentiation programme, we generated a RNAi-mediated stable knockdown of SUZ12, which constitutes a cornerstone for PRC2 assembly and functionality, in order to analyse intestinal cell proliferation and differentiation. Expression of SUZ12 was also investigated in human intestinal tissues, revealing the presence of SUZ12 in most proliferative epithelial cells of the crypt and an increase in its expression in colorectal cancers. Moreover, PRC2 disruption led to a significant precocious expression of a number of terminal differentiation markers in intestinal cell models. Taken together, our data identified a mechanism whereby PcG proteins participate in the repression of the enterocytic differentiation program, and suggest that a similar mechanism exists in situ to slow down terminal differentiation in the transit amplifying cell population.
Introduction
The epithelium of the small intestine is in continuous and rapid renewal. The dynamics of this system involves cell generation and migration from the stem cell population, located in the lower part of the crypt, to extrusion of senescent cells at the tip of the villus. The renewal kinetics of the intestinal epithelium has been characterized in great detail over the last three decades (Cheng and Leblond, 1974; Bjerknes and Cheng, 2005; Barker et al., 2008; Scoville et al., 2008; Potten et al., 2009; Quante and Wang, 2009; Li and Clevers, 2010; Shaker and Rubin, 2010) . These studies have established that the crypt contains two physically distinct proliferative compartments: the first, located in the lower third of the crypt containing the slow growing stem cells is called 'the stem cell zone' and the second, located in the middle of the crypt containing the fast growing and differentiating transit cells is called 'the transit amplifying (TA) zone'. Movement from the stem cell zone to the TA zone triggers the irreversible process of intestinal cell determination towards either secretory (mucous, enteroendocrine and Paneth cells) or absorptive (absorptive cells) lineages. Except for Paneth cell precursors that down-migrate and complete their differentiation at the crypt base, terminal differentiation occurs in the upper third of the crypt so that all cells reaching the villi are fully functional. More recent studies have yielded a wealth of complementary information involving signalling pathways such as Wnt, Bmp and Notch in intestinal stem cell regulation and lineage specification as well as evidence for the co-existence of two types of stem cells, the crypt base columnar cells and the label-retaining cells found at position ,4. Taken together, these observations indicate that the intestinal crypt is a highly hierarchized structure.
In agreement with The Unitarian Theory (Cheng and Leblond, 1974) , all cell lineages within the intestinal epithelium are derived from a common stem cell precursor (Barker and Clevers, 2010) . Specification for each lineage begins at a common origin just above the stem cell zone (approximately cell position 6 and above) (Bjerknes and Cheng, 2005) and involves Notch signalling (Yang et al., 2001) . It is well documented that the secretory population represents less that 10% of intestinal epithelial cells, the rest being absorptive cells. Absorptive cells thus need to divide several times more than secretory cells before undergoing terminal differentiation (Bjerknes and Cheng, 2005) in order to explain why absorptive cells are in the majority on the villi.
Minimal absorptive cell differentiation in the TA zone has been well documented in rodents with a variety of intestinal cell markers such as sucrase-isomaltase (SI) and apolipoproteins which are not detected in the crypt epithelium (Trier and Madara, 1981; Demmer et al., 1986; Traber, 1999; Sauvaget et al., 2002) , suggesting that absorptive cell differentiation is not induced in the TA zone. However, in man, some absorptive cell differentiation markers have been identified in the epithelium of the crypt. These include dipeptidylpeptidase IV (DPPIV) and aminopeptidase N (Gorvel et al., 1991; Quaroni et al., 1992) but also immature forms of other markers (Beaulieu et al., 1989; Beaulieu et al., 1990; Gorvel et al., 1991; Hoffman and Chang, 1993; Giannoni et al., 1995; Basque et al., 1998) including SI, one of the best characterized intestinal cell markers. The latter data are consistent with the fact that all cells in the TA zone express the transcription factors CDX2, HNF1a and HNF4a known to promote expression of differentiation markers such as SI (Traber, 1999; Mitchelmore et al., 2000; Boudreau et al., 2002b; Escaffit et al., 2005a; Olsen et al., 2005; Fang et al., 2006; Bosse et al., 2007; Boyd et al., 2009; Benoit et al., 2010; Boyd et al., 2010) . These data suggest that in the TA zone, repressive mechanisms are responsible for the full suppression of terminal differentiation in rodents. In man, the low levels of SI precursor in the human TA zone suggests an apparent leakiness in the mechanism(s) that repress terminal differentiation. Because of the existence of this leakiness, human intestinal cells represent an interesting system to investigate the mechanisms that repress differentiation in proliferating epithelial cells.
Mechanisms responsible for the transient repression of absorptive cell differentiation in the TA zone have not yet been investigated. Because the main pro-differentiation transcription factors are expressed in these cells, one may consider various mechanisms known to negatively modulate their transcriptional activity such as post-translational modifications (Houde et al., 2001; Rings et al., 2001) , expression of transcriptional repressors (Boudreau et al., 2002a) and/or epigenetic mechanisms such as histone modifications (Tou et al., 2004; Mariadason, 2008; Verzi et al., 2010) . Another possibility not yet investigated could be epigenetic control of gene expression via polycomb group (PcG) proteins. Indeed, PcGs have been extensively characterized for their ability to repress differentiation and promote self-renewal in embryonic stem cells via histone methylation Lee et al., 2006; Margueron and Reinberg, 2011 ), a step catalysed by the polycomb repressive complex 2 (PRC2) (Sparmann and van Lohuizen, 2006; Margueron and Reinberg, 2011) . The PRC2 core component SUZ12 is essential for the assembly, stability and functionality of PRC2 (Margueron and Reinberg, 2011) . While a role for PcGs in the preservation of stemness characteristics of embryonic stem cells is now well established, recent evidence has suggested that PcGs may have a more direct role in mediating cell differentiation (Caretti et al., 2004; Ezhkova et al., 2009 ) and cancer progression (Martinez-Garcia and Licht, 2010; Mills, 2010; Margueron and Reinberg, 2011) .
In the present study, we have investigated the potential implication of PcG-mediated epigenetic regulation in human intestinal cell differentiation. Our data show that inactivation of PRC2 leads to significant upregulation of specific terminal differentiation markers including SI in the two well characterized intestinal cell models Caco-2/15 and human intestinal epithelial crypt (HIEC) cells. In this context, predominant distribution of SUZ12 in the TA zone in the normal intestine and its detection in adenocarcinoma cells in primary tumours suggests that PcGs also exert repressive activity in situ on intestinal cell terminal differentiation and in colorectal tumour cells.
Results

PRC2 core member SUZ12 expression decreases as differentiation proceeds in human intestinal cells
The Caco-2/15 cell line has been widely exploited for its unique ability to spontaneously undertake a differentiation program upon reaching confluence, which is reflected by robust expression of specific biomarkers (Beaulieu and Quaroni, 1991; Sambuy et al., 2005) such as SI that increases with confluence (Fig. 1A) . The analysis of expression of the major polycomb factors constituting the PRC2 complex in Caco-2/15 cells revealed that transcripts encoding the SET-domain-containing histone methyltransferase EZH2, as well as its natural partner embryonic ectodermal development (EED) PcG protein, were constitutively expressed in Caco-2/15 cells (data not shown). Since previous findings have described that SUZ12 is essential for EZH2 and EED stabilization (Cao and Zhang, 2004) , we used the expression of SUZ12 at the protein level as a marker for functional PRC2 complexes in Caco-2/15 cell cultures at various stages of confluence. Western blot analyses revealed that SUZ12 was expressed in Caco-2/15 cells and that protein levels significantly decreased between 0 days post-confluence (PC) and 30 days PC, which inversely correlated with the appearance of SI (Fig. 1A) .
Disruption of PRC2 induces the enterocytic differentiation program of Caco-2/15 cells
To study the role of PRC2 in intestinal differentiation, RNAimediated stable knockdown of SUZ12 was generated in Caco-2/15 cells. These cultures showed significantly reduced protein levels of SUZ12 at all stages examined as compared to shCNS cultures (Fig. 1B) . Using an antibody directed against trimethylated lysine27 of histone 3 (H3K27me3), western blot analyses on shCNS and shSUZ12 protein lysates confirmed that the knockdown of SUZ12 was accompanied by a loss of PRC2 methyltransferase activity (Fig. 1B) .
The impact of the loss of SUZ12 on differentiation determined by measuring SI protein levels revealed a strikingly early appearance and higher levels of SI expression in confluent SUZ12 knockdown cell cultures compared to controls (Fig. 1C,D) . Since regulation of SI is mainly mediated by transcription factors HNF1a and CDX2, we examined the expression of these factors. Interestingly, while HNF1a rose gradually in Caco-2/15 cells between 0 and 8 days PC, no significant difference was noted between control and shSUZ12 cells (Fig. 1E) . Expression of other biomarkers associated with cell polarization such as villin, E-cadherin and Li-cadherin were not modulated by SUZ12 ablation (Fig. 1F) suggesting that PRC2 activity specifically targets terminal differentiation markers. To evaluate the functional relevance of the upregulated expression of SI in Caco-2/15 cells upon SUZ12 knockdown, SI mRNA levels were determined in control and shSUZ12 cells at 0, 4 and 8 days of postconfluence and compared to those of Caco-2/15 cells maintained at confluence up to 30 days. As shown in Fig. 2 , SI levels in shSUZ12 cells at 4 and 8 days were comparable to those observed in wild-type Caco-2 cells maintained at confluence for 12 and 30 days, respectively. However, the amounts of SI transcript never exceeded 25% of those found in the purified intestinal epithelium (Fig. 2) .
Distribution pattern of the PRC2 core factor SUZ12 in the human intestinal tract
The aforementioned results suggested that PRC2 activity participates in the repression of SI expression. To further explore PRC2 impedes terminal differentiation 3455 this hypothesis, the expression and distribution pattern of SUZ12 was studied by indirect immunofluorescence on cryosections of the normal human adult small intestine. As previously documented in detail in the human, SI is mainly expressed by the mature absorptive cells located in the terminal differentiation compartment and on the villus but also as weaker expression under a precursor form in the proliferative cells of the crypt (Beaulieu et al., 1989; Beaulieu et al., 1990) . Interestingly, as determined in matched serial adjacent sections ( Fig. 3A-D) , specific nuclear staining for SUZ12 was observed in the epithelial cells of the crypt that were negative for the mature form of SI (Fig. 3A ,B) but stained for the detection of the SI precursor (Fig. 3C,D) . SUZ12 was absent from the Paneth cells at the crypt bottom and villus enterocytes, stained with anti-group IIA phospholipase A2 (PLA2G2A) antibody and anti-mature SI antibody, respectively (Fig. 3B ). Further analyses on serial sections confirmed the mutually exclusive patterns of expression of SUZ12 and both mature SI and PLA2G2A, suggesting the presence of active PRC2 complex in the TA cells of the middle crypt (Fig. 3E ). Even though SUZ12 is predominantly expressed in the TA zone, the consistent expression of an immature form of SI, even detected at low levels, suggests that the repressive mechanism(s) counteracting the promoting effects of CDX2 and HNF1a on SI expression is leaky.
PRC2 impedes functional enterocytic differentiation in human normal crypt cells
The observation that SUZ12 expression was associated with the proliferative and poorly differentiated epithelial cell population in situ prompted the use of HIEC cells to further study the role of PRC2 on the enterocytic differentiation program. The HIEC model had been previously shown to display many characteristics associated with undifferentiated intestinal crypt cells (Perreault and Beaulieu, 1996; Pageot et al., 2000; Tremblay et al., 2006; Beaulieu and Ménard, 2012) . Ectopic expression of transcription factors such as HNF1a and CDX2 in HIEC induced initiation of an intestinal cell differentiation program (Benoit et al., 2010) . It is noteworthy that under these conditions, expression of cell polarization markers such as E-cadherin, Li-cadherin and various tight junction components was triggered while terminal differentiation remained limited as evaluated by expression of low levels of SI mRNA transcript. Taking together, these data indicating that HIEC HNF1a/CDX2 are committed but still poorly differentiated suggest that they may share characteristics with the TA cells (Benoit et al., 2010) . Consistent with this, we observed significant endogenous expression of the SUZ12 transcript in wildtype HIEC cells which was greatly increased following ectopic expression of HNF1a and CDX2 (Fig. 4A) . Adult small intestine total epithelium fractions were used as a reference point for SUZ12 expression. Hence, we hypothesized that the increased SUZ12 expression in committed HIEC could be related to the weak net effect of HNF1a and CDX2 on HIEC cell differentiation and that knocking down this PRC2 component would release repression of completion of the differentiation program.
We confirmed that the SUZ12 protein was endogenously expressed in HIEC cells and that it could be efficiently knocked down by shSUZ12 (Fig. 4B) . The abolition of SUZ12 expression was accompanied by the loss of an H3K27me3 signal, confirming the loss of PRC2 methylation activity (Fig. 4B) . As polycomb group protein actions are associated with repressed differentiation and maintained proliferative activity in other models (Margueron and Reinberg, 2011) , BrdU incorporation assays were performed to determine if SUZ12 knockdown affected cell growth in these normal cells. A significant decrease in BrdU incorporation was observed in shSUZ12 cells when compared to shCNS cells (Fig. 4C) . Furthermore, loss of PRC2 activity, via SUZ12 knockdown, was not sufficient to trigger the expression of HNF1a or CDX2 pro-enterocytic differentiation factors in HIEC cells (Fig. 4D) .
Consistent with the intestinal progenitor status of HIEC, previous studies confirmed the absence, or trace expression of digestive enzymes such as SI and DPPIV in wild-type cells (Perreault and Beaulieu, 1996; Pageot et al., 2000) but forced expression of HNF1a and CDX2 induced these enterocytic differentiation markers (Benoit et al., 2010) . The impact of SUZ12 abolition on differentiation was thus studied in wild type and HNF1a/CDX2 overexpressing HIEC. RT-PCR analyses showed that abolition of SUZ12 in wild type HIEC cultures did not significantly induce SI and DPPIV expression (Fig. 5A,B) . This result is in accordance with the above observations that SUZ12 knockdown is not sufficient to induce the HNF1a or CDX2 transcription (Fig. 1E,F9, Fig. 4D ) necessary for SI and DPPIV expression. In HIEC CDX2/HNF1a cells, however, abolition of SUZ12 resulted in a significant increase in SI and DPPIV mRNA expression (Fig. 5A,B) as well as that of lactasephlorizine hydrolase (LPH) and intestinal alkaline phosphatase (ALP), two other well-characterized enterocytic differentiation markers (Fig. 5C ). It is noteworthy that another wellcharacterized intestinal cell differentiation marker, fatty acid binding protein (FABPi), was not significantly modulated in response to SUZ12 depletion suggesting that not all terminal differentiation-related genes are under the dependence of the PRC2 complex. Furthermore, as observed in Caco-2/15 cells, SUZ12 knockdown in HIEC HNF1a/CDX2 cells failed to alter expression of polarization markers such as Li-cadherin (Fig. 5D ) and E-cadherin (not shown) but resulted in a significant decrease in the expression of CD44 and EpCAM (Fig. 5D) , two markers recently associated with colorectal cancer stem cells and invasiveness (Kuhn et al., 2007; Lugli et al., 2010; Hou et al., 2011) . Taken together, these results show that abolition of PRC2 epigenetic regulation via SUZ12 knockdown promotes the expression of a number, but not all terminal differentiation markers in normal intestinal cells.
Suz12 expression pattern in human colorectal cancers
Recent studies reported a putative role for the polycomb group proteins in solid tumour progression, including colorectal cancers (Fluge et al., 2009; Du et al., 2010; Mills, 2010; Margueron and Reinberg, 2011) . SUZ12 expressing human colorectal cancers were first analysed by quantitative PCR (qPCR) in patientmatched pairs of colon resection margins and corresponding primary carcinoma samples. On average with 44 cases tested, a significantly higher expression of SUZ12 was observed in the tumour group (Fig. 6A, column A) . Analysing each pair individually revealed that 12 of the cases exhibited a 26 or higher increased expression of SUZ12 in the tumour sample compared to normal tissue. However, higher levels of SUZ12 expression was not correlated with tumour stage as shown in Fig. 6A (r 2 50.038; P50.75, not significant) nor with tumour grade (r 2 50.074; P50.65, not significant). In order to determine the SUZ12 distribution pattern in such a pathological context, indirect immunofluorescence experiments were performed on 16 different human colonic adenocarcinoma cases. E-cadherin coimmunostaining was carried out to distinguish the epithelial organized regions from stromal cells. Of the cases studied, all well-differentiated adenocarcinomas displayed limited SUZ12 positive staining (three cases; not shown), while the abundance of SUZ12-positive nuclei in epithelial structures varied from 'weak' to 'strong' in the moderately differentiated samples (10 cases) as shown in two representative samples (Fig. 6B,C) . Although tested in a limited number of samples (three cases), relative abundant SUZ12-positive nuclei were observed in poorly differentiated tumours (not shown). .052), the cell-cell junction marker Li-cadherin (n53, non-significant), and the stem-cell-associated markers CD44 and EpCAM (n53, *P50.0127, **P50.0099) were also evaluated by qPCR in shCNS and shSUZ12 committed HIEC cells. In all cases, RPLP0 amplification was used as a control reference gene. 
Discussion
A tightly coordinated balance between proliferation and differentiation is essential for the intestinal epithelium to preserve its constant renewing capacity. The crypt-villus axis of the small intestine confines the proliferative/stem cell population from the differentiated absorptive cells in two physically distinct regions, the crypt and the villus. As cells move out of the stem cell region they become committed to either an absorptive lineage or a secretory lineage. Bjerknes and Cheng provided experimental evidence that absorptive progenitors divide approximately four times before terminal differentiation while secretory progenitors divide only once or twice (Bjerknes and Cheng, 2005) explaining why absorptive cells are so strongly in the majority on the villi. While polycomb group proteins have been extensively described as regulators of pluripotency and selfrenewal in human and murine stem cells Lee et al., 2006; Margueron and Reinberg, 2011) , little is known about the participation of such epigenetic transcriptional regulatory mechanisms in committed cells outside the stem cell niche. Our findings showing that abolition of PRC2 activity in two experimental cell models triggers acceleration of absorptive cell terminal differentiation markers such as SI suggests that epigenetic regulation by PRC2 is a novel mechanism involved in regulating the balance between intestinal absorptive cell amplification and differentiation, summarized in Fig. 7 . Based on this model, we propose that PRC2 activity allows TA cells to maintain their proliferation potential while delaying acquisition of a number of terminal differentiation characteristics. Moreover, we describe the distribution pattern of SUZ12 in human colorectal cancer and found a significant increase of this marker of PRC2 activity in 27% of the tumours, suggesting that PcG might play a role in cancer progression in at least a subset of patients.
PRC2 core members, EZH2, EED1/2 and SUZ12, were found to be expressed in the human intestinal epithelial models Caco-2/ 15 and HIEC, and in order to study PRC2 involvement in the differentiation of these two models, we disrupted this complex by RNAi-based knockdown of SUZ12. Previous studies have shown the critical importance of SUZ12 in PRC2 assembly and subsequent EZH histone methyltransferase activity (Cao and Zhang, 2004) . EZH1 has previously been shown to have the capacity to compensate for the loss of EZH2 among PRC2. (n519) and IV (n58). The average change of relative SUZ12 transcript expression for the 44 cancer pairs (A) was found to be statistically significant (P50.0007, paired t-test).
(B,C) Immunodetection of SUZ12 in representative moderately differentiated human colon carcinoma sections showing variable staining intensity (weak, 1; moderate, 2; strong, 3). Epithelial structures were counterstained using anti-E-cadherin and nuclei were stained with DAPI. Scale bar: 50 mm. and HNF1a and express basal levels of the components responsible for PRC2 histone methyltransferase activity (PRC2 HMTase). Exit from the stem cell niche and entry into the transit amplifying zone coincides with induction of CDX2 and HNF1a, which enhances expression of the PRC2 HMTase activity machinery. Only basal levels of enterocyte differentiation markers such as SI are detected in these proliferating cells. The loss of PRC2 HMTase activity in cells reaching the terminal differentiation compartment triggers a reduction of cell proliferation and allows for full enterocytic differentiation. Thus, although transcription factors CDX2 and HNF1a are responsible for the ultimate expression of the enterocyte differentiation markers such SI, their expression is repressed by PcGs in the expanding cell population of the transit amplifying zone.
Moreover, four distinct EED isoforms, which can be differentially used by the cell in specific physiological/ pathological contexts, were also identified (Margueron and Reinberg, 2011) . In order to limit any compensation mechanisms by known isoforms of PRC2 core proteins, we opted for SUZ12 knockdown as a way to silence PcG-mediated histone methyltransferase activity. H3K27 tri-methylation, a hallmark of PRC2 activity (Sparmann and van Lohuizen, 2006; Martinez-Garcia and Licht, 2010; Margueron and Reinberg, 2011) , was shown to be efficiently downregulated following SUZ12 knockdown in both Caco-2/15 and HIEC cells.
SI expression has been extensively characterized as a major enterocyte terminal differentiation marker (Beaulieu and Quaroni, 1991; Boudreau et al., 2002b; Benoit et al., 2010) . Significant SI induction was found to occur earlier when PRC2 was silenced in the human intestinal differentiation model Caco-2/15. We and others have previously demonstrated the importance of CDX2 and HNF1a transcription factors in SI induction (Boudreau et al., 2002b; Benoit et al., 2010; Boyd et al., 2010) . No significant changes in either CDX2 or HNF1a expression were observed in PRC2 invalidated cells ruling out a differential effect of these factors on precocious induction of SI expression.
In the intact small intestine, SUZ12 was found to be predominantly expressed in the cells of the TA zone, being below detection levels in villus and Paneth cells, both terminally differentiated. Interestingly, the pro-differentiation transcription factors HNF1a and CDX2 are expressed by virtually all intestinal committed epithelial cells in the normal small intestine, including those of the TA zone (Traber, 1999; Mitchelmore et al., 2000; Boudreau et al., 2002b; Escaffit et al., 2005a; Olsen et al., 2005; Fang et al., 2006; Bosse et al., 2007; Benoit et al., 2010) . These observations suggest that epigenetic PRC2 activity may participate in the mechanism responsible for counteracting the pro-differentiation influence of CDX2 and HNF1a in the TA cells before they reach the terminal differentiation compartment. Abolition of PRC2 activity results in significant enhancement of SI expression in Caco-2/15 cells but one may argue that this result may not necessary reflect the normal situation considering the cancerous nature of Caco-2/15 cells. Therefore, this hypothesis was further investigated using the human normal intestinal epithelial crypt HIEC cells (Perreault and Beaulieu, 1996) . Previous studies on HIEC cells showed that they expressed intestinal epithelial crypt cell markers such as epithelial keratins, junctional proteins, a trace of DPPIV, MIM-1/39, integrin a6b4, a8b1 and a9b1 (Perreault and Beaulieu, 1996; Desloges et al., 1998; Basora et al., 1999; Pageot et al., 2000; Benoit et al., 2009; Beaulieu and Ménard, 2012) but no Ecadherin, CDX2, HNF1a or SI (Escaffit et al., 2005a; Escaffit et al., 2005b; Escaffit et al., 2006; Benoit et al., 2010) . Forced expression of CDX2 and HNF1a in HIEC resulted in the expression of polarization/junctional markers such as E-and Licadherin, a decrease in the expression of stem cell related markers such as DCAMKL1 and Mushashi-1 and the induction of SI and DPPIV expression (Benoit et al., 2010) . Considering that these phenotypic changes resulting from the expression of CDX2 and HNF1a expression were reminiscent of what occurs in position 6-7 and above in the normal crypt (Escaffit et al., 2005a; Escaffit et al., 2005b; Escaffit et al., 2006; Benoit et al., 2010) , including expression of detectable levels of the two terminal intestinal cell differentiation markers SI and DPPIV (Beaulieu et al., 1989; Quaroni et al., 1992) , we hypothesized that HIEC CDX2/HNF-1a cells may mimic the in vivo situation in the TA zone. If right, abolition of the PRC2 repressive influence should result in enhancement of terminal differentiation features such as SI and DPPIV expression and remain without significant effect on polarization markers such as E-cadherin. As expected, knock down of SUZ12 in HIEC CDX2/HNF-1a cells caused a significant increase in the differentiation markers SI and DPPIV as well as lactase-phlorizin hydrolase and intestinal alkaline phosphatase, two other digestive brush border enzymes associated with the terminal differentiated phenotype (Mitchelmore et al., 2000) and did not affect E-and Licadherins as observed in Caco-2/15 cells. This phenomenon diverges from studies performed in embryonic stem cells where PRC2 activity can regulate E-cadherin repression (Herranz et al., 2008) . The data presented herein on committed cells points out a distinct role for PRC2 activity in cells located outside of the stem cell compartments, restraining their terminal differentiation. It has to be pointed out however that not all terminal differentiation markers have their expression controlled by PRC2 activity as illustrated with intestinal fatty acid binding protein, another wellcharacterized intestinal terminal differentiation marker (Levy et al., 2009) .
Interestingly, PRC2 inactivation in HIEC caused a decreased expression of the epithelial cell adhesion molecule EpCAM and the cell-surface antigen CD44. Both proteins have been reported to be expressed in the proliferative cells of normal crypts (MerlosSuárez et al., 2011) . EpCAM expression has recently been shown to be under PcG control in human embryonic stem cells, being specifically expressed by undifferentiated embryonic stem cells and repressed upon differentiation (Lu et al., 2010) . Moreover, the transcriptionally active EpCAM gene was associated with high H3K27 trimethylation at the promoter region. On the other hand, CD44 expression has been observed in colon tumour-initiating cells and was associated with an aggressive phenotype (MerlosSuárez et al., 2011) . Remarkably, both EpCAM and CD44 were identified, along with claudin-7 and tetraspanin CO-029, as members of a complex which promotes colorectal cancer progression and apoptosis resistance (Lugli et al., 2010) .
Many recent studies have suggested a participation of PcGs in the progression of human cancers, including colon (Fluge et al., 2009; Du et al., 2010; Mills, 2010; Margueron and Reinberg, 2011) . On this basis, and considering the association between PRC2 and the proliferative region of the crypt-villus axis, we investigated SUZ12 expression and its distribution pattern in human colon adenocarcinomas. SUZ12 expression was found to be increased in a significant portion of the colorectal cancer pairs tested but there was no correlation with either the stage or grade of the tumours and the nuclear staining was found to be relatively heterogeneous in the primary tumours. These results suggest that overexpression of SUZ12 may define a subset of colon cancers.
Taken together, these data establish a new molecular mechanism limiting terminal differentiation in the intestinal cell proliferative compartment. Indeed, besides the previously reported inhibitory mechanisms of intestinal cell differentiation (Houde et al., 2001; Rings et al., 2001; Boudreau et al., 2002a; Tou et al., 2004; Mariadason, 2008; Verzi et al., 2010) detailed above, our studies using the two distinct intestinal cells models Caco-2/15 and HIEC CDX2/HNF-1a showed that the activity of the PRC2 component of PcG specifically repressed the expression of a number of terminal differentiation markers. In situ, the cornerstone PRC2 component SUZ12 was identified in a significant proportion of colon tumours and found predominantly in the TA zone in the normal small intestine suggesting that PcG proteins may also participate in the repressive mechanism of terminal differentiation in vivo.
Materials and Methods
Tissues
Tissues from the normal adult proximal ileum were obtained from Quebec Transplant (Quebec, Canada) in accordance with protocols approved by the local Institutional Human Subject Review Board for the use of human material. Forty four patient-matched pairs of colon resection margins and primary tumour samples were obtained from the Cooperative Human Tissue Network (n515), funded by the National Cancer Institute, and from patients undergoing surgical resection at the Centre Hospitalier Universitaire de Sherbrooke (n529). Patients did not receive neoadjuvant chemotherapy or radiotherapy. Tissues were obtained after patient's written informed consent, according to a protocol approved by the Institutional Human Subject Review Board. In all cases, clinical and pathological information were obtained from medical records. Patient's cancers were histologically classified and graded according to overall TNM staging criteria (based on tumour, lymph node and metastatic status). Tissue arrays of colonic adenocarcinomas, including pathology diagnosis and tumour grade, were purchased at US Biomax Inc (Rockville, MD).
Cell culture and establishment of SUZ12 knockdown HIEC and Caco-2/15 cells Human intestinal crypt HIEC cells have been characterized elsewhere (Perreault and Beaulieu, 1996; Pageot et al., 2000) and extensively used as a human intestinal crypt cell model (Beaulieu and Ménard, 2012) . CDX2/HNF1a inducible HIEC cells were used as a normal human differentiation model and were cultured as recently described (Benoit et al., 2010) . Caco-2/15 cells were used as a wellcharacterized human intestinal differentiation model. Their characterization and culture conditions have been previously described (Beaulieu and Quaroni, 1991; Vachon and Beaulieu, 1992) . Stable shRNA SUZ12 knockdown (shSUZ12) and control non-silencing (shCNS) HIEC and Caco-2/15 cell populations were established by lentiviral infection which allowed for an optimal rate of gene transfer and long-term transgene expression. The pLKO.1-puro vector containing SUZ12-silencing (shSUZ12) and luciferase-silencing (shCNS) short hairpin RNA were purchased from Sigma-Aldrich (MISSION shRNA). The five pLKO.1/ shSUZ12 and pLKO.1/shCNS vectors were used to produce virus in 293T cells as previously described (Benoit et al., 2009 ). Sub-confluent HIEC and Caco-2/15 cells were infected with viral suspensions and selected for 10 days with 10 mg/ml puromycin to generate stable cell populations. Four of shSUZ12 were found to be efficient in blocking SUZ12 expression (not shown).
Indirect immunofluorescence staining
The preparation and optimum cutting temperature (OCT; Canemco-Marivac, Lakefield, QC) embedding of specimens, cryosectioning as well as staining procedures were performed as previously described (Escaffit et al., 2005b; Benoit et al., 2010) . Paraffin-embedded tissue arrays were rehydrated, prior to immunostaining, as previously described. The rabbit monoclonal antibody targeting the human Suppressor of Zeste 12 (SUZ12; D39F6, Cell Signaling) was used at a 1:2000 dilution while the mouse monoclonal antibodies targeting the mature and immature forms of human sucrase-isomaltase (HSI-5 and HSI-13, respectively) were produced and characterized as described previously (Beaulieu and Quaroni, 1991 ) and used at a 1:500 dilution. Rabbit polyclonal antibody raised against the Paneth cell specific PLA2G2A was used at a 1:5000 dilution (H-74, Santa Cruz Biotech). Mouse monoclonal antibody used for E-cadherin detection was used at a 1:5000 dilution (BD Biosciences). Secondary antibodies were FITCconjugated anti-mouse and anti-rabbit (Chemicon). Nuclei were stained with DAPI.
Western blot analysis
Proteins were extracted, separated by SDS-PAGE and transferred onto nitrocellulose membranes as previously described (Perreault and Beaulieu, 1996; Escaffit et al., 2005a) . Membranes were blocked in PBS containing 5% skim milk and 0.1% Tween 20 (Bio-Rad). The rabbit monoclonal anti-SUZ12 (D39F6, Cell Signaling, 1:1000), rabbit polyclonal anti-H3K27me3 (07-449, Millipore, 1:5000), goat polyclonal anti-HNF1a (C-19, Santa Cruz Biotech, 1:500), mouse monoclonal anti-sucrase-isomaltase (HSI-14, 1:10) (Beaulieu and Quaroni, 1991) , anti-Cdx2 (88, Biogenex, 1:500), anti-E-cadherin (36, BD Biosciences, 1:2000), anti-Li-cadherin (C-17, Santa Cruz Biotech, 1:500) and anti-actin (C4, 1:75,000, Chemicon) were incubated with membranes for 12 hours at 4˚C in blocking solution. After washing in PBS, membranes were incubated with horseradish peroxidase-conjugated secondary antibodies (anti-mouse, anti-rabbit, Amersham) and developed using the Immobilon Western kit (Millipore).
RNA extraction, RT-PCR and quantitative PCR
Total RNA was extracted using TriPure isolation reagent (Roche). mRNA was reverse-transcribed using the reverse transcriptase Omniscript (Qiagen). PCR assays were performed as described previously (Dydensborg et al., 2006; Benoit et al., 2009) . Human SI, CDX2, HNF1a, Li-cadherin, DPPIV, B2M and RPLP0 were evaluated by qPCR as previously described (Escaffit et al., 2005a; Dydensborg et al., 2006; Escaffit et al., 2006; Benoit et al., 2010) . For EZH2 detection we used the forward 59-TTTTTGCCAAGAGAGCCATC-39 and the reverse 59-AAGGC-AGCTGTTTCAGAGGA-39 primers while EED (variants 1 and 2) was detected using the forward 59-CGATGGTTAGGCGATTTGAT-39 and the reverse 59-CCAAATGTCACACTGGCTGT-39 primers. For human SUZ12 detection, the forward 59-TGAAACTCTGGAATCTCCATGTC-39 and the reverse 59-TGCATGCTGACTAGATGAAGC-39 primers were used. For lactase-phlorizine hydrolase detection we used the forward 59-GCCACAGGCTTTTCAGAGAG-39 and the reverse 59-GAACTGCACCTCCTCCTGTC-39 primers, intestinal fatty acid binding protein (FABP2) was detected using the forward 59-AACTGAACTCA-GGGGGACCT-39 and the reverse 59-CCTTTTGGCTTCTACTCCTTCA-39 primers, intestinal alkaline phosphatase (ALPI) was detected using the forward 59-TCCCCTCAGGTTGTTCTCTG-39 and the reverse 59-CCAAGTCCTTGGGTC-TACCA-39 primers, CD44 was detected using the forward 59-TAAGGACACC-CCAAATTCCA-39 and the reverse 59-CCACATTCTGCAGGTTCCTT-39 primers, and EpCAM was detected using the forward 59-CACAACGCGTTATCAACTGG-39 and the reverse 59-CCAGCTTTTAGACCCTGCAT-39 primers. Due to technical limitations that prevented a PCR efficiency of between 90% and 110%, LPH PCR amplification products were migrated on an agarose gel and the optical density of the bands were quantified using Scion Image software (NIH).
BrdU incorporation assays
BrdU incorporation experiments in cells were performed in accordance with the In Situ Cell Proliferation Kit FLUOSH protocol (Roche) as described previously (Benoit et al., 2009 ).
Statistical analysis
Data were expressed as means 6 s.e.m. Each experiment was repeated at least three times and representative results were shown. All values were subjected to the two-tailed Student's t-test. P,0.05 was considered significant.
